Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.081 | 0.7 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.7 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |